Cargando…

Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles

INTRODUCTION: Alzheimer’s disease (AD) is associated with neurofibrillary pathology, including neurofibrillary tangles (NFT), neuritic plaques (NP) and neuropil threads containing aggregated microtubule associated protein tau. Aggregated tau is also associated with granulovacuolar degeneration (GVD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Hunter, Sally, Minett, Thais, Polvikoski, Tuomo, Mukaetova-Ladinska, Elizabeta, Brayne, Carol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551529/
https://www.ncbi.nlm.nih.gov/pubmed/26315613
http://dx.doi.org/10.1186/s13195-015-0141-2
_version_ 1782387580880289792
author Hunter, Sally
Minett, Thais
Polvikoski, Tuomo
Mukaetova-Ladinska, Elizabeta
Brayne, Carol
author_facet Hunter, Sally
Minett, Thais
Polvikoski, Tuomo
Mukaetova-Ladinska, Elizabeta
Brayne, Carol
author_sort Hunter, Sally
collection PubMed
description INTRODUCTION: Alzheimer’s disease (AD) is associated with neurofibrillary pathology, including neurofibrillary tangles (NFT), neuritic plaques (NP) and neuropil threads containing aggregated microtubule associated protein tau. Aggregated tau is also associated with granulovacuolar degeneration (GVD). The relationships between tau, GVD, NFT and dementia are unclear. METHODS: We assessed hippocampal (CA1) tau-immunoreactive GVD and NFT pathology in brain donations from the population-representative Cambridge City over 75s Cohort (CC75C) using the CERAD protocol and a modified protocol that included a morphological characterisation of tau-immunoreactive deposits within neurons as NFTs or as GVD. Associations between GVD, NFT and dementia were investigated. RESULTS: Hippocampal pyramidal neurons affected with either NFT or GVD are common in the older population. Some tau-immunoreactive deposits resemble ghost GVD neurons. Tau immunoreactivity identified GVD in 95 % cases rated as none with haematoxylin and eosin staining. Both severe NFT (odds ratio (OR) 7.33, 95 % confidence interval (CI) 2.01; 26.80, p = 0.003) and severe GVD (OR 7.48, 95 %(CI) 1.54; 36.24, p = 0.012) were associated with dementia status. Increasing NFT (OR 2.47 95 %(CI) 1.45; 4.22, p = 0.001) and GVD (OR 2.12 95 %(CI) 1.23; 3.64, p = 0.007) severities are associated with increasing dementia severity. However, when the analyses were controlled for other neuropathologies (NFT, NP, Tar-DNA binding Protein-43 and amyloid deposits), the associations between GVD and dementia lost significance. CONCLUSIONS: Current neuropathological assessments do not adequately evaluate the presence and severity of the GVD pathology and its contribution to dementia remains unclear. We recommend that protocols to assess GVD should be developed for routine use and that tau, in a non-PHF associated conformation, is reliably associated with GVD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13195-015-0141-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4551529
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45515292015-08-29 Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles Hunter, Sally Minett, Thais Polvikoski, Tuomo Mukaetova-Ladinska, Elizabeta Brayne, Carol Alzheimers Res Ther Research INTRODUCTION: Alzheimer’s disease (AD) is associated with neurofibrillary pathology, including neurofibrillary tangles (NFT), neuritic plaques (NP) and neuropil threads containing aggregated microtubule associated protein tau. Aggregated tau is also associated with granulovacuolar degeneration (GVD). The relationships between tau, GVD, NFT and dementia are unclear. METHODS: We assessed hippocampal (CA1) tau-immunoreactive GVD and NFT pathology in brain donations from the population-representative Cambridge City over 75s Cohort (CC75C) using the CERAD protocol and a modified protocol that included a morphological characterisation of tau-immunoreactive deposits within neurons as NFTs or as GVD. Associations between GVD, NFT and dementia were investigated. RESULTS: Hippocampal pyramidal neurons affected with either NFT or GVD are common in the older population. Some tau-immunoreactive deposits resemble ghost GVD neurons. Tau immunoreactivity identified GVD in 95 % cases rated as none with haematoxylin and eosin staining. Both severe NFT (odds ratio (OR) 7.33, 95 % confidence interval (CI) 2.01; 26.80, p = 0.003) and severe GVD (OR 7.48, 95 %(CI) 1.54; 36.24, p = 0.012) were associated with dementia status. Increasing NFT (OR 2.47 95 %(CI) 1.45; 4.22, p = 0.001) and GVD (OR 2.12 95 %(CI) 1.23; 3.64, p = 0.007) severities are associated with increasing dementia severity. However, when the analyses were controlled for other neuropathologies (NFT, NP, Tar-DNA binding Protein-43 and amyloid deposits), the associations between GVD and dementia lost significance. CONCLUSIONS: Current neuropathological assessments do not adequately evaluate the presence and severity of the GVD pathology and its contribution to dementia remains unclear. We recommend that protocols to assess GVD should be developed for routine use and that tau, in a non-PHF associated conformation, is reliably associated with GVD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13195-015-0141-2) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-28 /pmc/articles/PMC4551529/ /pubmed/26315613 http://dx.doi.org/10.1186/s13195-015-0141-2 Text en © Hunter et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hunter, Sally
Minett, Thais
Polvikoski, Tuomo
Mukaetova-Ladinska, Elizabeta
Brayne, Carol
Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles
title Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles
title_full Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles
title_fullStr Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles
title_full_unstemmed Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles
title_short Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles
title_sort re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551529/
https://www.ncbi.nlm.nih.gov/pubmed/26315613
http://dx.doi.org/10.1186/s13195-015-0141-2
work_keys_str_mv AT huntersally reexaminingtauimmunoreactivepathologyinthepopulationgranulovacuolardegenerationandneurofibrillarytangles
AT minettthais reexaminingtauimmunoreactivepathologyinthepopulationgranulovacuolardegenerationandneurofibrillarytangles
AT polvikoskituomo reexaminingtauimmunoreactivepathologyinthepopulationgranulovacuolardegenerationandneurofibrillarytangles
AT mukaetovaladinskaelizabeta reexaminingtauimmunoreactivepathologyinthepopulationgranulovacuolardegenerationandneurofibrillarytangles
AT braynecarol reexaminingtauimmunoreactivepathologyinthepopulationgranulovacuolardegenerationandneurofibrillarytangles
AT reexaminingtauimmunoreactivepathologyinthepopulationgranulovacuolardegenerationandneurofibrillarytangles